Home › Gastrointestinal Stromal Tumors › California
Gastrointestinal Stromal Tumors clinical trials in California
11 studies for Gastrointestinal Stromal Tumors are looking for participants at sites in California.
Cities in California
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
- GSK Investigational Site, Duarte
- GSK Investigational Site, La Jolla
- GSK Investigational Site, Los Angeles
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07218926A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)
- GSK Investigational Site, San Francisco
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07585266A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- City of Hope - Duarte Cancer Center, Duarte
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06760819DESTINY-PANTUMOUR04
- Research Site, San Diego
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
- USC Norris Comprehensive Cancer Center, Los Angeles
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT07406633A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Precision NextGen Oncology & Research Center, Beverly Hills
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
- University of California Los Angeles Rheumatology, Westwood, Los Angeles
RecruitingPhase 2
Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
- University of Southern California - Norris Comprehensive Cancer Center, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT05957367Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor
- University of California, San Diego, La Jolla
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 27, 2026 · NCT07171203A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
- University of California, San Diego, La Jolla
- University of Southern California, Los Angeles
- University Of California, Irvine, Orange
- and 2 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT06655246A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
- UC San Diego Moores Cancer Center, La Jolla
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT06630234Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- Stanford University School of Medicine, Stanford
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT01048281From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.